Cristalmina (Chlorhexidine Digluconate)

Antiseptic solution for wound disinfection and skin antisepsis

Prescription (Rx) ATC: D08AC02 Antiseptic & Disinfectant
Active Ingredient
Chlorhexidine digluconate
Available Forms
Solution (topical)
Strength
10 mg/ml (1%)
Brand Names
Cristalmina
Medically reviewed | Last reviewed: | Evidence level: 1A
Cristalmina is a topical antiseptic solution containing chlorhexidine digluconate at a concentration of 10 mg/ml (1%). It is used for disinfecting the skin and cleaning minor wounds, cuts, and abrasions. Chlorhexidine is one of the most widely used antiseptics in healthcare settings worldwide, valued for its broad-spectrum antimicrobial activity and long-lasting residual effect on the skin.
📅 Published:
🔄 Updated:
Reading time: 12 minutes
Written and reviewed by iMedic Medical Editorial Team

Quick Facts About Cristalmina

Active Ingredient
Chlorhexidine
digluconate
Drug Class
Antiseptic
Biguanide disinfectant
ATC Code
D08AC02
Chlorhexidine
Common Uses
Wound care
Skin disinfection
Available Forms
Solution
10 mg/ml topical
Prescription Status
Rx
Prescription required

Key Takeaways About Cristalmina

  • Broad-spectrum antiseptic: Chlorhexidine is effective against gram-positive and gram-negative bacteria, some fungi, and enveloped viruses
  • Long-lasting protection: Provides up to 24 hours of residual antimicrobial activity after a single application due to skin protein binding
  • For external use only: Never apply to the eyes, ears (middle ear), brain, or meninges — serious harm can result
  • Avoid soap before use: Soap and anionic detergents inactivate chlorhexidine — rinse thoroughly before applying
  • Safe in pregnancy: Minimal systemic absorption makes it generally safe for topical use during pregnancy and breastfeeding

What Is Cristalmina and What Is It Used For?

Cristalmina is a topical antiseptic solution containing chlorhexidine digluconate 10 mg/ml. It is used for skin disinfection and wound cleaning. Chlorhexidine kills bacteria by disrupting their cell membranes and provides long-lasting antimicrobial protection on the skin surface.

Cristalmina belongs to the biguanide class of antiseptics. Its active ingredient, chlorhexidine digluconate, is one of the most thoroughly studied and widely used antiseptics in modern medicine. The World Health Organization (WHO) includes chlorhexidine on its Model List of Essential Medicines, recognizing its importance in infection prevention worldwide.

Chlorhexidine was first developed in the 1950s by Imperial Chemical Industries in the United Kingdom and has since become a cornerstone of infection control in both hospital and community settings. It is valued for its broad-spectrum antimicrobial activity, its ability to remain active on the skin for extended periods (known as substantivity), and its relatively low toxicity when used topically.

At the concentration found in Cristalmina (1% or 10 mg/ml), the solution is effective for cleaning and disinfecting skin wounds and can be used for preoperative skin preparation in some settings. The solution is typically clear and colourless, making it easy to apply without staining the skin or wound area.

Common Uses of Cristalmina

Cristalmina is indicated for a range of antiseptic applications in clinical and home settings:

  • Minor wound disinfection: Cleaning cuts, scrapes, abrasions, and minor burns to prevent infection
  • Preoperative skin antisepsis: Preparing the skin before minor surgical or dermatological procedures
  • Umbilical cord care: Disinfection of the umbilical cord stump in newborns, as recommended by WHO in settings with high neonatal infection rates
  • Catheter site care: Cleaning skin around indwelling catheters and intravenous access sites
  • Post-procedural wound cleaning: Disinfection after stitches, biopsies, or other skin procedures

How Does Chlorhexidine Work?

Chlorhexidine exerts its antimicrobial action through a well-understood mechanism. The positively charged chlorhexidine molecule is attracted to the negatively charged bacterial cell membrane. At low concentrations, it acts as a bacteriostatic agent, inhibiting bacterial growth by disrupting the cell membrane and causing leakage of small intracellular molecules. At higher concentrations, such as those in Cristalmina, it becomes bactericidal, causing irreversible damage to the cell membrane and precipitation of cytoplasmic contents, leading to cell death.

One of chlorhexidine's most distinctive properties is its substantivity — the ability to bind to skin proteins and mucosal surfaces and continue to exert antimicrobial activity for up to 24 hours after application. This residual activity makes chlorhexidine particularly valuable in surgical settings and wound management, where ongoing protection against bacterial colonization is important.

Chlorhexidine is effective against a broad range of microorganisms, including gram-positive bacteria (such as Staphylococcus aureus and Streptococcus species), gram-negative bacteria (including Pseudomonas aeruginosa and Escherichia coli), and some yeasts and fungi. It also has activity against enveloped viruses such as herpes simplex virus and HIV. However, it has limited activity against bacterial spores, mycobacteria, and non-enveloped viruses.

Clinical Significance:

Multiple systematic reviews and meta-analyses have demonstrated that chlorhexidine-based skin antisepsis reduces the incidence of surgical site infections compared to povidone-iodine. A landmark Cochrane review found that chlorhexidine skin preparation before surgery may reduce the risk of wound infection by approximately 36% compared to iodine-based solutions.

What Should You Know Before Using Cristalmina?

Before using Cristalmina, be aware that it is for external use only and must never be applied to the eyes, ears, brain, or meninges. Avoid using it if you are allergic to chlorhexidine. Do not combine it with soap or iodine-based antiseptics. Consult your healthcare provider before using on large wounds, deep burns, or in neonates.

While chlorhexidine is generally well tolerated and has a good safety profile for topical use, there are important precautions to consider before using Cristalmina. Understanding these warnings can help you use the product safely and effectively.

Contraindications

Cristalmina should not be used in the following situations:

  • Known allergy to chlorhexidine: Hypersensitivity reactions to chlorhexidine, though uncommon, can be severe and include anaphylaxis. If you have previously experienced a rash, itching, breathing difficulties, or swelling after exposure to chlorhexidine-containing products, do not use Cristalmina
  • Application to the eyes: Chlorhexidine can cause serious corneal damage and is not suitable for ophthalmic use
  • Application to the middle ear: If the eardrum is perforated, chlorhexidine can cause sensorineural deafness (ototoxicity)
  • Contact with the brain or meninges: Neurotoxicity has been reported when chlorhexidine has come into contact with neural tissue during surgery
  • Use as a body cavity irrigant: Chlorhexidine should not be used to irrigate body cavities or introduced into the bladder

Warnings and Precautions

Exercise caution in the following circumstances:

  • Deep or extensive wounds: Chlorhexidine may delay wound healing in deep surgical wounds and large areas of damaged tissue. For deep wounds, consult a healthcare professional for appropriate wound management
  • Large burns: Avoid use on extensive burns as systemic absorption may increase and cause adverse effects
  • Premature and low birth weight infants: Chemical skin burns have been reported in neonates, particularly premature infants with immature skin. Use with extreme caution and under medical supervision only
  • Mucous membranes: While some formulations of chlorhexidine are designed for mucosal use (such as mouth rinses), Cristalmina solution is intended for skin application. Avoid contact with mucous membranes unless specifically directed by your healthcare provider
  • Skin sensitivity: Prolonged or repeated use may lead to contact dermatitis in some individuals. Discontinue use if significant irritation develops
Important Safety Warning

Chlorhexidine-containing products are flammable when applied to skin. Allow the solution to dry completely before exposure to open flames, electrocautery, or other heat sources. Cases of severe burns have been reported when surgical drapes were placed over wet chlorhexidine solution during procedures involving diathermy or electrosurgery.

Pregnancy and Breastfeeding

Chlorhexidine has minimal systemic absorption when applied topically to intact or minor wounded skin. Based on decades of clinical use and available safety data, it is generally considered safe for use during pregnancy. The WHO recommends chlorhexidine for umbilical cord care in newborns in high-mortality settings, reflecting confidence in its safety profile around the time of delivery.

During breastfeeding, Cristalmina can generally be used on areas away from the breasts. Avoid applying chlorhexidine to the nipple or areola area before breastfeeding, as the infant could ingest the product. If chlorhexidine has been applied to the breast, wash the area thoroughly with water before nursing. As with all medications during pregnancy and breastfeeding, consult your healthcare provider for individual advice.

How Does Cristalmina Interact with Other Substances?

Cristalmina can be inactivated by soap and anionic detergents. It should not be mixed with iodine-based antiseptics. Since it is applied topically with minimal systemic absorption, significant drug interactions with oral or injectable medications are not expected.

As a topically applied antiseptic with minimal systemic absorption, Cristalmina has a limited interaction profile compared to systemic medications. However, several important local interactions can affect its efficacy and safety.

Known interactions with Cristalmina (chlorhexidine)
Interacting Substance Type Effect Recommendation
Soap & anionic detergents Major Inactivates chlorhexidine through chemical incompatibility Rinse area thoroughly with water before applying Cristalmina
Povidone-iodine Major Mutual inactivation; forms a brown precipitate that can irritate the skin Do not mix or use simultaneously on the same area
Cork and organic matter Moderate Can reduce antimicrobial activity (though less than with iodine) Clean wound debris before applying
Hard water minerals Minor Calcium and magnesium ions may slightly reduce chlorhexidine activity Use as directed; clinical significance is minimal
Nonionic surfactants Minor High concentrations of nonionic surfactants may reduce activity Allow previous products to dry before applying Cristalmina

Major Interactions

The most clinically significant interaction is with soap and anionic detergents. These substances carry a negative charge that directly neutralizes the positively charged chlorhexidine molecule, rendering it inactive. This is why it is essential to rinse the skin thoroughly with water after washing with soap before applying Cristalmina. Even small amounts of residual soap can significantly reduce the antiseptic's effectiveness.

Povidone-iodine (Betadine and similar products) should not be used simultaneously with chlorhexidine on the same wound or skin area. The two antiseptics are chemically incompatible and can form a brown precipitate that reduces the efficacy of both agents and may cause additional skin irritation. If switching between these antiseptics, thoroughly clean the area before applying the alternative product.

Minor Interactions

Other topical preparations, including emollients, barrier creams, and wound dressings, generally do not significantly interfere with chlorhexidine activity. However, it is good practice to allow Cristalmina to dry completely on the skin before applying additional topical products or wound dressings to ensure optimal antimicrobial activity.

Because chlorhexidine undergoes minimal systemic absorption through the skin, interactions with oral or injectable medications (such as antibiotics, blood thinners, or diabetes medications) are not expected and have not been reported in clinical practice.

What Is the Correct Dosage of Cristalmina?

Cristalmina solution is applied directly to the affected skin area using a gauze pad or spray. For wound cleaning, apply once or twice daily or as directed by your healthcare provider. There is no specific dose — use enough to thoroughly wet the area. Allow to air dry for maximum effect.

Unlike oral medications, Cristalmina does not follow traditional dosage regimens measured in milligrams per kilogram. The amount used depends on the size of the wound or skin area to be treated. The general principle is to apply enough solution to thoroughly wet the area being disinfected.

Adults

Standard Adult Application

Minor wounds and cuts: Apply Cristalmina solution directly to the clean wound using a sterile gauze pad or spray nozzle. Cover the entire wound and surrounding skin (approximately 2-3 cm around the wound edge). Apply once or twice daily, or each time the dressing is changed.

Preoperative skin preparation: Apply liberally to the surgical site and surrounding area. Allow to air dry for at least 2 minutes before proceeding. A second application may be required for heavily contaminated areas.

General skin disinfection: Apply to the area using a gauze pad or cotton swab. Allow to air dry completely.

Children

Pediatric Application

Children over 2 years: Same application method as adults. Apply to the wound or skin area using a sterile gauze pad. Use the minimum amount needed to cover the affected area.

Infants and toddlers (under 2 years): Use only under medical supervision. Apply with extra care, avoiding large areas of skin. Chlorhexidine can be absorbed more readily through immature skin.

Neonates: Use only on medical advice. For umbilical cord care, apply a small amount to the cord stump as directed by the midwife or pediatrician. Monitor closely for skin reactions, especially in premature infants.

Elderly

Application in Elderly Patients

No dosage adjustment is needed for elderly patients. Apply as for adults. However, elderly patients may have thinner or more fragile skin, so monitor for irritation, particularly with prolonged or repeated use. Skin dryness may be more pronounced in older adults.

Dosage Guidelines for Cristalmina by Patient Group
Patient Group Application Method Frequency Special Notes
Adults Apply to wound/skin with gauze or spray 1-2 times daily or at dressing change Allow to air dry; avoid soap contact
Children (>2 years) Same as adults 1-2 times daily Use minimum amount needed
Infants (<2 years) Apply with care to limited area As directed by physician Medical supervision required
Neonates Small amount to cord stump As directed by midwife/pediatrician Risk of chemical burns in premature infants
Elderly Same as adults 1-2 times daily Monitor for skin dryness/irritation

Missed Application

If you forget to apply Cristalmina at the scheduled time, apply it as soon as you remember. There is no risk of "overdosing" from a missed application. Simply resume your regular application schedule. If the wound has been left uncovered and exposed to potential contamination, clean the wound gently with water before reapplying Cristalmina.

Overdose and Excessive Application

Topical overdose with Cristalmina is unlikely to cause systemic harm, as chlorhexidine has very low systemic absorption through intact skin. However, applying excessive amounts to very large areas of damaged skin or deep wounds could theoretically increase absorption. If accidental ingestion occurs, seek medical attention. Chlorhexidine is poorly absorbed from the gastrointestinal tract, but gastric lavage may be considered in cases of large ingestions. Supportive care is the mainstay of treatment for any accidental exposure.

What Are the Side Effects of Cristalmina?

Most people tolerate Cristalmina well. Common side effects include mild skin irritation and dryness at the application site. Uncommon side effects include contact dermatitis. Rare but serious reactions include allergic reactions (including anaphylaxis), chemical burns in neonates, and ototoxicity if it reaches the middle ear.

Chlorhexidine has been used extensively for over 60 years and has a well-established safety profile for topical application. Most side effects are mild and localized to the application site. However, healthcare professionals and patients should be aware of rare but potentially serious adverse reactions.

Common

May affect up to 1 in 10 people

  • Mild skin irritation at the application site
  • Transient stinging or burning sensation on application
  • Skin dryness with repeated use
  • Mild redness (erythema) at the site of application

Uncommon

May affect up to 1 in 100 people

  • Contact dermatitis (itchy, red, flaking skin)
  • Photosensitivity (increased sun sensitivity at application site)
  • Skin discolouration (temporary brownish staining)
  • Delayed wound healing (with prolonged use on deep wounds)

Rare

May affect up to 1 in 1,000 people

  • Allergic reactions (urticaria, angioedema)
  • Anaphylaxis (severe, life-threatening allergic reaction)
  • Chemical burns (especially in premature neonates)
  • Ototoxicity (hearing damage if solution enters the middle ear)

The most common side effects are mild and transient, typically resolving without treatment after the product is discontinued or the skin adapts to the product. Contact dermatitis is an uncommon but recognised side effect, presenting as a delayed hypersensitivity reaction with itching, redness, and skin peeling. If this occurs, discontinue use and consult a healthcare provider.

Anaphylaxis to chlorhexidine is rare but has been increasingly recognised in recent decades. Reports have described severe allergic reactions occurring during medical and dental procedures where chlorhexidine-coated devices or solutions are used. Patients who have experienced urticaria (hives) or angioedema (swelling) after previous chlorhexidine exposure should be considered potentially at risk and should avoid all chlorhexidine-containing products. The UK Medicines and Healthcare products Regulatory Agency (MHRA) and the US FDA have both issued safety communications regarding this risk.

When to Seek Immediate Medical Help

Seek emergency medical attention if you experience signs of a severe allergic reaction after applying Cristalmina, including difficulty breathing, swelling of the face, lips, tongue, or throat, widespread hives, rapid heartbeat, or feeling faint. Although rare, anaphylaxis to chlorhexidine can be life-threatening and requires immediate treatment.

In neonates, particularly premature infants with immature skin barrier function, chemical burns have been reported with chlorhexidine use. These burns can range from mild erythema to full-thickness skin injury. The risk is highest in infants born before 32 weeks of gestation and those weighing less than 1,500 grams. Healthcare providers should use the lowest effective concentration and duration when chlorhexidine is necessary in this population.

How Should You Store Cristalmina?

Store Cristalmina at room temperature (below 25°C) in its original container, protected from light and heat. Do not freeze. Keep out of reach of children. Do not use after the expiry date printed on the packaging. Once opened, use within the manufacturer's recommended timeframe.

Proper storage of Cristalmina ensures that the solution maintains its antimicrobial activity and safety throughout its shelf life. Chlorhexidine solutions are generally stable when stored correctly, but certain conditions can degrade the active ingredient or compromise sterility.

  • Temperature: Store at room temperature, ideally between 15°C and 25°C. Avoid exposure to temperatures above 30°C, as high heat can accelerate degradation of the active ingredient
  • Light: Keep the bottle in its original outer packaging to protect from direct sunlight, which can reduce potency over time
  • Freezing: Do not freeze the solution. Freezing and thawing can alter the formulation and potentially reduce efficacy
  • Container: Use the original container. Do not transfer to other containers, as certain plastics or metals can interact with chlorhexidine and reduce its activity. Cork stoppers should be avoided as they can absorb and inactivate chlorhexidine
  • Children: Keep out of sight and reach of children. Accidental ingestion can cause nausea, vomiting, and gastrointestinal irritation
  • Expiry date: Do not use Cristalmina after the expiry date printed on the label and carton. Once opened, follow the manufacturer's instructions for the in-use shelf life

Chlorhexidine solutions can become contaminated with microorganisms if stored improperly or if unsterile instruments are introduced into the container. Reports of outbreaks linked to contaminated chlorhexidine solutions, particularly with organisms such as Burkholderia cepacia and Serratia marcescens, underscore the importance of maintaining aseptic technique when using the product. Always close the cap tightly after use and never top up partially used containers with fresh solution.

What Does Cristalmina Contain?

The active ingredient in Cristalmina is chlorhexidine digluconate at a concentration of 10 mg/ml (1%). The solution also contains purified water and may contain additional excipients to maintain stability and pH.

Cristalmina is a clear, colourless to pale yellow aqueous solution. Its composition is relatively simple compared to many pharmaceutical preparations:

  • Active ingredient: Chlorhexidine digluconate 10 mg/ml (equivalent to 1% w/v). Chlorhexidine digluconate is the water-soluble salt form of chlorhexidine, which enables it to be formulated as an aqueous solution
  • Solvent: Purified water (aqua purificata) forms the base of the solution
  • Excipients: The formulation may contain small amounts of pH-adjusting agents to maintain the optimal pH range (5.5–7.0) for chlorhexidine activity and stability

The solution is free from alcohol, making it suitable for use in situations where alcohol-based antiseptics may be contraindicated or undesirable, such as on sensitive skin, in neonates, or near open flames during surgical procedures. However, this also means that the solution relies solely on chlorhexidine for its antimicrobial action, without the additional rapid-kill effect that alcohol provides in alcohol-chlorhexidine combination products.

Chlorhexidine digluconate itself is a synthetic compound with the molecular formula C22H30Cl2N10 · 2C6H12O7. It is a dicationic bisbiguanide with a molecular weight of approximately 897.8 g/mol. The digluconate salt was chosen for pharmaceutical formulations because of its high water solubility, which allows for the preparation of stable aqueous solutions.

Note for People with Allergies:

Cristalmina does not contain latex, preservatives other than the active ingredient itself, fragrances, or common allergenic excipients. However, always check the full list of ingredients on the product packaging if you have known sensitivities. If you have a history of allergic reactions to chlorhexidine-containing products (including mouth rinses, wound dressings, or antiseptic wipes), do not use this product.

Frequently Asked Questions About Cristalmina

Medical References and Sources

Evidence Level: This article is based on Level 1A evidence from systematic reviews, meta-analyses of randomized controlled trials, and international clinical guidelines. All references are from peer-reviewed sources.

  1. World Health Organization. WHO Model List of Essential Medicines – 23rd List (2023). Geneva: WHO; 2023. Chlorhexidine included as an antiseptic.
  2. Dumville JC, McFarlane E, Edwards P, Lipp A, Holmes A, Liu Z. Preoperative skin antiseptics for preventing surgical wound infections after clean surgery. Cochrane Database of Systematic Reviews. 2015;(4):CD003949. doi:10.1002/14651858.CD003949.pub4
  3. Darouiche RO, Wall MJ Jr, Itani KMF, et al. Chlorhexidine-Alcohol versus Povidone-Iodine for Surgical-Site Antisepsis. New England Journal of Medicine. 2010;362(1):18-26. doi:10.1056/NEJMoa0810988
  4. World Health Organization. WHO Recommendations on Newborn Health: Guidelines Approved by the WHO Guidelines Review Committee. Geneva: WHO; 2017. Chlorhexidine for umbilical cord care.
  5. European Medicines Agency. Summary of Product Characteristics – Chlorhexidine preparations. EMA assessment reports.
  6. Medicines and Healthcare products Regulatory Agency (MHRA). Chlorhexidine solutions: reminder of the risk of chemical burns in premature infants. Drug Safety Update. 2014;7(12):S2.
  7. Opstrup MS, Jemec GBE, Garvey LH. Chlorhexidine allergy: on the rise and often overlooked. Current Allergy and Asthma Reports. 2019;19(5):23. doi:10.1007/s11882-019-0858-2
  8. International Wound Infection Institute (IWII). Wound Infection in Clinical Practice: Principles of Best Practice. Wounds International; 2022.
  9. British National Formulary (BNF). Chlorhexidine – Skin cleansers, antiseptics and desloughing agents. NICE; 2024.
  10. US Food and Drug Administration. FDA Drug Safety Communication: FDA warns about rare but serious allergic reactions with the skin antiseptic chlorhexidine gluconate. 2017.

About Our Medical Editorial Team

This article has been written and medically reviewed by the iMedic Medical Editorial Team, consisting of licensed specialist physicians in clinical pharmacology, dermatology, and infection control with documented academic backgrounds and clinical experience.

📋 Peer Review Process

All medical content is reviewed by at least two licensed specialist physicians before publication.

🔍 Fact-Checking

All medical claims are verified against peer-reviewed sources and international guidelines.

🔄 Update Frequency

Content is reviewed and updated at least every 12 months or when new research emerges.

✎ Corrections Policy

Any errors are corrected immediately with transparent changelog. Read more

Medical Editorial Board: iMedic has an independent medical editorial board consisting of specialist physicians in clinical pharmacology, dermatology, infection control, and wound management.